These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 36086988)

  • 41. Peripherally Restricted Cannabinoids for the Treatment of Pain.
    Romero-Sandoval EA; Asbill S; Paige CA; Byrd-Glover K
    Pharmacotherapy; 2015 Oct; 35(10):917-25. PubMed ID: 26497478
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficacy and adverse effects of medical marijuana for chronic noncancer pain: Systematic review of randomized controlled trials.
    Deshpande A; Mailis-Gagnon A; Zoheiry N; Lakha SF
    Can Fam Physician; 2015 Aug; 61(8):e372-81. PubMed ID: 26505059
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cannabinoids for the Treatment of Chronic Non-Cancer Pain: An Updated Systematic Review of Randomized Controlled Trials.
    Lynch ME; Ware MA
    J Neuroimmune Pharmacol; 2015 Jun; 10(2):293-301. PubMed ID: 25796592
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Topical analgesics for acute and chronic pain in adults - an overview of Cochrane Reviews.
    Derry S; Wiffen PJ; Kalso EA; Bell RF; Aldington D; Phillips T; Gaskell H; Moore RA
    Cochrane Database Syst Rev; 2017 May; 5(5):CD008609. PubMed ID: 28497473
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The role of cannabinoids in pain control: the good, the bad, and the ugly.
    Pergolizzi JV; Lequang JA; Taylor R; Raffa RB; Colucci D;
    Minerva Anestesiol; 2018 Aug; 84(8):955-969. PubMed ID: 29338150
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Canadian clinical practice guidelines for the use of plant-based cannabis and cannabinoid-based products in the management of chronic non-cancer pain and co-occurring conditions: protocol for a systematic literature review.
    Wright P; Walsh Z; Margolese S; Sanchez T; Arlt S; Belle-Isle L; St Pierre M; Bell A; Daeninck P; Gagnon M; Lacasse G; MacCallum C; Mandarino E; Yale J; O'Hara J; Costiniuk C
    BMJ Open; 2020 May; 10(5):e036114. PubMed ID: 32448797
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Role of cannabinoids in the treatment of pain and (painful) spasticity.
    Karst M; Wippermann S; Ahrens J
    Drugs; 2010 Dec; 70(18):2409-38. PubMed ID: 21142261
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cannabinoids: Medical implications.
    Schrot RJ; Hubbard JR
    Ann Med; 2016; 48(3):128-41. PubMed ID: 26912385
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cannabinoids for Treatment of MS Symptoms: State of the Evidence.
    Rice J; Cameron M
    Curr Neurol Neurosci Rep; 2018 Jun; 18(8):50. PubMed ID: 29923025
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Should cannabinoids be used as analgesics for neuropathic pain?
    Rice AS
    Nat Clin Pract Neurol; 2008 Dec; 4(12):654-5. PubMed ID: 19015657
    [No Abstract]   [Full Text] [Related]  

  • 51. Cannabinoids, cannabis, and cannabis-based medicines for pain management: an overview of systematic reviews.
    Moore RA; Fisher E; Finn DP; Finnerup NB; Gilron I; Haroutounian S; Krane E; Rice ASC; Rowbotham M; Wallace M; Eccleston C
    Pain; 2021 Jul; 162(Suppl 1):S67-S79. PubMed ID: 32804833
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy, tolerability and safety of cannabinoids in chronic pain associated with rheumatic diseases (fibromyalgia syndrome, back pain, osteoarthritis, rheumatoid arthritis): A systematic review of randomized controlled trials.
    Fitzcharles MA; Baerwald C; Ablin J; Häuser W
    Schmerz; 2016 Feb; 30(1):47-61. PubMed ID: 26767993
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Recent data on cannabinoids and their pharmacological implications in neuropathic pain.
    Coman OA; Paunescu H; Coman L; Badarau A; Fulga I
    J Med Life; 2008; 1(4):365-75. PubMed ID: 20108515
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A systematic review of pharmacological pain management in multiple sclerosis.
    Jawahar R; Oh U; Yang S; Lapane KL
    Drugs; 2013 Oct; 73(15):1711-22. PubMed ID: 24085618
    [TBL] [Abstract][Full Text] [Related]  

  • 55. International Association for the Study of Pain Presidential Task Force on Cannabis and Cannabinoid Analgesia: research agenda on the use of cannabinoids, cannabis, and cannabis-based medicines for pain management.
    Haroutounian S; Arendt-Nielsen L; Belton J; Blyth FM; Degenhardt L; Di Forti M; Eccleston C; Finn DP; Finnerup NB; Fisher E; Fogarty AE; Gilron I; Hohmann AG; Kalso E; Krane E; Mohiuddin M; Moore RA; Rowbotham M; Soliman N; Wallace M; Zinboonyahgoon N; Rice ASC
    Pain; 2021 Jul; 162(Suppl 1):S117-S124. PubMed ID: 34138827
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Cannabis and cannabinoids-easier access, hype and disappointment : What has been confirmed in therapy?].
    Rasche T; Emmert D; Stieber C; Conrad R; Mücke M
    Internist (Berl); 2019 Mar; 60(3):309-314. PubMed ID: 30680416
    [TBL] [Abstract][Full Text] [Related]  

  • 57. General risks of harm with cannabinoids, cannabis, and cannabis-based medicine possibly relevant to patients receiving these for pain management: an overview of systematic reviews.
    Mohiuddin M; Blyth FM; Degenhardt L; Di Forti M; Eccleston C; Haroutounian S; Moore A; Rice ASC; Wallace M; Park R; Gilron I
    Pain; 2021 Jul; 162(Suppl 1):S80-S96. PubMed ID: 32941319
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacological management of chronic neuropathic pain: revised consensus statement from the Canadian Pain Society.
    Moulin D; Boulanger A; Clark AJ; Clarke H; Dao T; Finley GA; Furlan A; Gilron I; Gordon A; Morley-Forster PK; Sessle BJ; Squire P; Stinson J; Taenzer P; Velly A; Ware MA; Weinberg EL; Williamson OD;
    Pain Res Manag; 2014; 19(6):328-35. PubMed ID: 25479151
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Emerging role of cannabinoids and synthetic cannabinoid receptor 1/cannabinoid receptor 2 receptor agonists in cancer treatment and chemotherapy-associated cancer management.
    Shah SA; Gupta AS; Kumar P
    J Cancer Res Ther; 2021; 17(1):1-9. PubMed ID: 33723124
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antinociceptive effects of minor cannabinoids, terpenes and flavonoids in Cannabis.
    Rodriguez CEB; Ouyang L; Kandasamy R
    Behav Pharmacol; 2022 Apr; 33(2&3):130-157. PubMed ID: 33709984
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.